Trials / Completed
CompletedNCT04884347
Evaluation of the Efficacy of a Food Supplement in Reducing Hair Loss in Male Subjects
Double Blind, Randomized, Placebo-controlled Assessment of the Efficacy of a Food Supplement in Reducing Hair Loss in Male Subjects
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Laboratoires Pharmaceutiques Trenker · Industry
- Sex
- Male
- Age
- 25 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
According to the American Hair Loss Association, by the age of 35, two-thirds of American men will have some degree of appreciable hair loss, and by the age of 50, approximately 50 to 85% of men will have significant hair thinning. Hair is an essential aspect of human appearance and can have a significant impact on a person's self-esteem, mood and quality of life. Unfortunately, current treatment options can be costly, tedious or painful. They are also associated with numerous side effects. Here, the investigators aimed at evaluating the effect of a new food supplement on hair condition in young men suffering from hair loss. A second goal was to determine tolerability.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Alline proMEN | 1 tablet per day intake during the meal with a glass of water. Treatment duration: 3 months |
| DIETARY_SUPPLEMENT | Placebo | 1 tablet per day intake during the meal with a glass of water. Treatment duration: 3 months |
Timeline
- Start date
- 2020-08-31
- Primary completion
- 2021-02-04
- Completion
- 2021-02-04
- First posted
- 2021-05-13
- Last updated
- 2021-05-13
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT04884347. Inclusion in this directory is not an endorsement.